Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

ZOLL MEDICAL CORPORATION

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

ZOLL MEDICAL CORPORATION

Regulatory records
23
Linked recall entries
8
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 23 FDA records to the applicant name ZOLL MEDICAL CORPORATION. It includes 2 original PMA approvals. 14 entries are PMA supplements. 7 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from May 26, 2017 to Oct 16, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code MKJ appears in 21 of the 23 linked filings. The collection spans 3 FDA product codes and 5 original PMA application families. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P160022, with 13 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 4 linked filings have a current plain-language explanation checked against the recorded FDA decision.

Applicant mailing address recorded by FDA: 269 & 271 Mill Rd., Chelsmford, MA, 01824. Recorded on P160015/S029, decision dated Oct 16, 2026.

Changes described in PMA records

P160015/S029: AED 3 Defibrillator with Uni-Padz

FDA's database lists P160015/S029 for ZOLL Medical Corporation's AED 3 Defibrillator with Uni-Padz as a normal 180-day-track PMA supplement without user fee, approved 2026-10-16. The supplement reason is postapproval study protocol, and the statement describes approval of a protocol for the post-approval study to replace the original PAS protocol.

Because S029 is a supplement to P160015, it modifies an element of that existing approval rather than approving the device system anew. The statement says the submitted PAS protocol complies with conditions of approval in the P160015/S001 order. It does not report PAS results, so it is not evidence of safety or clinical effectiveness; the replacement protocol's design, endpoints and timeline are absent.

FDA approval-order wording

approval of the protocol for the post-approval study (PAS) referenced above to replace the original PAS protocol. The PAS protocol has been submitted to comply with the conditions of approval outlined in the approval order for P160015/S001.

Oct 16, 2026 · Normal 180 Day Track No User Fee

P160022/S056: ZOLL R Series Monitor/Defibrillator

The FDA recorded decision OK30 on 2026-10-16 for PMA supplement P160022/S056, submitted by ZOLL Medical Corporation for the ZOLL R Series Monitor/Defibrillator. The supplement is filed as a 30-Day Notice with a recorded reason of process change affecting manufacturer, sterilizer, packager or supplier. The listed device category is automated external defibrillators (non-wearable), specialty Cardiovascular, product code MKJ.

The recorded statement describes an alternate critical component on the printed circuit board assembly. That scope concerns a component-level change within the existing PMA, not a new approval of the whole monitor/defibrillator system. The source record does not identify the specific component, the supplier, or the basis for the decision, and no supporting documents are listed, so the technical and clinical significance of the substitution cannot be assessed from this data alone.

FDA approval-order wording

an alternate critical component on the printed circuit board assembly

Oct 16, 2026 · 30-Day Notice

P160022/S054: X Series, R Series, AED Pro, AED 3 BLS Professional Defibrillators, Pro-Padz Radiotransparent Electrode, SurePower

ZOLL Medical Corporation filed a 30-Day Notice, supplement S054 to PMA P160022, recorded with decision OK30 on 2026-10-02. The database lists the change as "an alternate electrode manufacturing line" under the reason Process Change - Manufacturer/Sterilizer/Packager/Supplier. The named device grouping covers X Series, R Series, AED Pro and AED 3 BLS professional defibrillators, the Pro-Padz Radiotransparent Electrode and SurePower, within the non-wearable automated external defibrillator category (product code MKJ).

The S054 identifier frames this as a supplement to the existing PMA rather than an original approval, and a manufacturing notice does not constitute approval of the whole system. The database field does not identify which electrode or component the alternate line produces, its location, qualification data, or any FDA review finding beyond the stated decision code; the notice's purpose should not be read as independent evidence of safety or clinical effectiveness. Whether the alternate line applies to Pro-Padz, another electrode, or the defibrillator units themselves is absent.

FDA approval-order wording

an alternate electrode manufacturing line

Oct 2, 2026 · 30-Day Notice

P110024/S007: ResQCPR System

FDA’s recorded scope: a component supplier manufacturing site change for the Timing Assist Light Board

Aug 27, 2026 · 30-Day Notice

P160015/S028: AED 3; CPR Uni-Padz

FDA’s recorded scope: approval of the revised protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in the approval order for P160015/S001.

Jul 16, 2026 · Normal 180 Day Track No User Fee

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

RECALL COVERAGE

Recalls linked to this firm

MedtechLedger links 8 FDA enforcement entries through the recorded recalling firm or an exact submission number published in FDA’s recall data. 8 Class II records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.

Recall / productCompanyClassificationReport dateSource
ZOLL MEDICAL CORPORATIONClass IIMar 19, 2025FDA
ZOLL MEDICAL CORPORATIONClass IIMar 19, 2025FDA
ZOLL MEDICAL CORPORATIONClass IIMar 19, 2025FDA
ZOLL MEDICAL CORPORATIONClass IIMar 19, 2025FDA
ZOLL MEDICAL CORPORATIONClass IIMar 19, 2025FDA
ZOLL MEDICAL CORPORATIONClass IIMar 19, 2025FDA

Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.

Search the firm’s recall records
Source information

Source updated Nov 11, 2026. Retrieved Nov 21, 2026.

Regulatory record history

Product / regulatory recordCompanyPathwayDecision dateSource
ZOLL MEDICAL CORPORATIONPMA supplementOct 16, 2026FDA
ZOLL MEDICAL CORPORATIONPMA supplementOct 16, 2026FDA
ZOLL MEDICAL CORPORATIONPMA supplementOct 2, 2026FDA
ResQCPR SystemP110024/S007
ZOLL MEDICAL CORPORATIONPMA supplementAug 27, 2026FDA
ZOLL MEDICAL CORPORATIONPMA supplementJul 16, 2026FDA
ZOLL MEDICAL CORPORATIONPMA supplementJul 14, 2026FDA
ZOLL MEDICAL CORPORATIONPMA supplementJun 5, 2026FDA
ZOLL MEDICAL CORPORATIONPMA supplementMay 20, 2026FDA
Powerheart G5P160033/S011
ZOLL MEDICAL CORPORATIONPMA supplementApr 28, 2026FDA
ZOLL MEDICAL CORPORATIONPMA supplementApr 28, 2026FDA
ZOLL MEDICAL CORPORATIONPMA supplementDec 30, 2025FDA
AED 3P160015/S025
ZOLL MEDICAL CORPORATIONPMA supplementDec 18, 2025FDA
ZOLL MEDICAL CORPORATIONPMA supplementDec 18, 2025FDA
ZOLL MEDICAL CORPORATIONPMA supplementDec 9, 2025FDA
ZOLL MEDICAL CORPORATIONPMA supplementSep 29, 2025FDA
ZOLL MEDICAL CORPORATIONPMA supplementSep 22, 2025FDA
ZOLL MEDICAL CORPORATIONPMA supplementSep 22, 2025FDA
ZOLL MEDICAL CORPORATIONPMA supplementAug 28, 2025FDA
ZOLL MEDICAL CORPORATIONPMA supplementAug 28, 2025FDA
ZOLL MEDICAL CORPORATIONPMA supplementJul 24, 2025FDA
ZOLL MEDICAL CORPORATIONPMA supplementJul 23, 2025FDA
ZOLL MEDICAL CORPORATIONPMA approvalDec 27, 2017FDA
ZOLL MEDICAL CORPORATIONPMA approvalMay 26, 2017FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.